RAD51 paralogs promote genomic integrity and chemoresistance in cancer by facilitating homologous recombination

Cancer is a major health burden, however advances in early diagnosis and improved surgery and therapeutic options have improved outcomes over the past several decades. Nevertheless, many radiological and chemotherapeutic treatments yield severe side effects, while relapse and subsequent outgrowth of treatment resistant tumours is common.